About
Cajal Therapeutics develops novel small molecule and RNA-based medicines to restore iron homeostasis for treating diseases such as anemias of inflammation, neurodegenerative diseases, and other iron-related disorders.
Explore Cajal Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.